Golvatinib Uses, Dosage, Side Effects and more
Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.
| Attribute | Details |
|---|---|
| Trade Name | Golvatinib |
| Generic | Golvatinib |
| Golvatinib Other Names | Golvatinib |
| Type | |
| Formula | C33H37F2N7O4 |
| Weight | Average: 633.701 Monoisotopic: 633.287509025 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
